AR and breast cancer: Given that LSD1 could also function as a coactivator via demethylating H3K9me1/2 and activating transcription by interacting with androgen receptor (AR) and ER, two receptors that mediated the BC progression (48, 49), it is identified as a promising target for BC therapy (49).